RecruitingNot ApplicableNCT07459309
Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies
Sponsor
Fudan University
Enrollment
20 participants
Start Date
Apr 13, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Multimodal Tumor Thermal Ablation for people with liver ablation and liver cancer (primary and metastatic). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEMultimodal Tumor Thermal Ablation
Multimodal Tumor Thermal Ablation
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07459309
Related Trials
Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment
NCT075872161 location
Stereotactic Liver Ablation Assisted With Intra-Arterial CT Hepatic Arteriography and Ablation Confirmation Software Assessment (STEREOLAB)
NCT053615511 location
Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy
NCT074454121 location
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
NCT074106761 location
The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases
NCT073855211 location